FDA issued a Warning Letter to Biosyntrx on 2/26/2015 as a result of this inspection.
483 Biosyntrx Sep 2014

483 Biosyntrx Sep 2014

Larisa Pavlick FDA$119.00 - Available Now

FDA investigators audited the Biosyntrx - Colorado Springs, CO, United States facility and issued inspectional observations (via FDA 483) on 05 Sep 2014.

Product details

  • Category: Foods & Cosmetics
  • Inspection end: 05 Sep 2014
  • Location: Colorado Springs, United States
  • FEI: 3010344617
Add To Cart